NK Cells and Curing Cancer with Dr. Nina Horowitz
Published on
September 13, 2022
Sep 13, 2022
Our CEO, Dr. Nina Horowitz – then Head of R&D, NK– was interviewed on Axial podcast about NK cell biology, her academic career, and her motivation to find novel cures for the patients who need them.
About Axial
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio and Seranova Bio often when they are no more than an idea.
Listen to the podcast here.
Contact Us
hello@immunebridge.com
2122 Bryant St, San Francisco, CA 94110